To achieve this goal, MRF has developed a unique business/science hybrid model for medical research that is speeding the time to drug discovery by as much as 200%. This new research model, called the Accelerated Research Collaboration™ (ARC™) model. To learn more about the Foundation and our research initiatives, go to www.myelinrepair.org.

Read the Myelin Repair Foundation Blog to keep up-to-date on our research.

The Myelin Repair Foundation recently launched WhereAreTheCures.org to educate patients & others on the barriers that are slowing the delivery of patient treatments and the innovators who are challenging the status quo. Visit & sign The Patient's Manifesto!

Scott Johnson Named Finalist in Ernst & Young Entrepreneur of the Year Award 

The Northern California Chapter of the Ernst & Young Entrepreneur Of The Year® award today announced 25 finalists in its 2010 award program. This recognition is given to entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Scott is one of only two finalists among the 25 representing the non-profit sector. 

See Ernst & Young News announcement. 

MRF is mentioned in the cover story of Newsweek. Sharon Begley and Mary Carmichael, of Newsweek magazine, are asking the tough questions about where the cures are for diseases such as MS. In their recent cover story, Desperately Seeking Cures, they explore the National Institutes of Health’s (NIH) failing research method of “here’s some money; go discover something,” in order to emphasize the positive outcome from a model that is not only founded on the cooperation of scientists sharing their discoveries with each other before they are published but also the developmental footwork that is necessary after those discoveries are made.  A model like theAccelerated Research Collaboration (ARC) we use here at the Myelin Repair Foundation, which caused MRF to get mentioned in the article along with other private foundations.